Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8)
Clinical trial NCT01769378 · COMPLETED
Trial details
- NCT number
- NCT01769378
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2014-12-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.